Skip to Main content Skip to Navigation
Journal articles

Drug Discovery for Kinetoplastid Diseases: Future Directions

Srinivasa Rao 1, * Michael Barrett 2 Glenn Dranoff 3 Christopher Faraday 3 Claudio Gimpelewicz 4 Asrat Hailu 5 Catherine Jones 1 John Kelly 6 Janis Lazdins-Helds Pascal Mäser 7 Jose Mengel 8, 9 Jeremy Mottram 10 Charles Mowbray 11 David Sacks 12 Phillip Scott 13 Gerald F Späth 14 Rick Tarleton 15 Jonathan Spector 1 Thierry Diagana 1, *
* Corresponding author
1 NITD - Novartis Institute for Tropical Diseases
2 University of Glasgow
3 NIBR - Novartis Institutes for BioMedical Research
4 Novartis Pharma AG
5 AAU - Addis Ababa University
6 LSHTM - London School of Hygiene and Tropical Medicine
7 Swiss Tropical and Public Health Institute [Basel]
8 FIOCRUZ - Fundação Oswaldo Cruz
9 UCP - Universidade Católica de Petrópolis
10 University of York [York, UK]
11 Drugs for Neglected Diseases Initiative
12 NIAID-NIH - National Institute of Allergy and Infectious Diseases [Bethesda]
13 Penn State - Pennsylvania State University
14 Institut Pasteur [Paris]
15 University of Georgia [USA]
Abstract : Kinetoplastid parasites have caused human disease for millennia. Significant achievements have been made toward developing new treatments for leishmaniasis (particularly on the Indian subcontinent) and for human African trypanosomiasis (HAT). Moreover, the sustained decrease in the incidence of HAT has made the prospect of elimination a tantalizing reality. Despite the gains, no new chemical or biological entities to treat kinetoplastid diseases have been registered in more than three decades, and more work is needed to discover safe and effective therapies for patients with Chagas disease and leishmaniasis. Advances in tools for drug discovery and novel insights into the biology of the host-parasite interaction may provide opportunities for accelerated progress. Here, we summarize the output from a gathering of scientists and physicians who met to discuss the current status and future directions in drug discovery for kinetoplastid diseases.
Document type :
Journal articles
Complete list of metadata

Cited literature [4 references]  Display  Hide  Download
https://hal-pasteur.archives-ouvertes.fr/pasteur-01974311
Contributor : Christel Ricard Andraos Connect in order to contact the contributor
Submitted on : Tuesday, January 8, 2019 - 4:53:26 PM
Last modification on : Wednesday, November 3, 2021 - 9:31:01 AM

File

Vignette du document
acsinfecdis.8b00298.pdf

Licence

Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike 4.0 International License

Identifiers

Collections

PASTEUR | RIIP

Citation

Srinivasa Rao, Michael Barrett, Glenn Dranoff, Christopher Faraday, Claudio Gimpelewicz, et al.. Drug Discovery for Kinetoplastid Diseases: Future Directions. ACS Infectious Diseases, American Chemical Society, 2018, ⟨10.1021/acsinfecdis.8b00298⟩. ⟨pasteur-01974311⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Les métriques sont temporairement indisponibles